頁面路徑選單
- 首頁
- 市場技術報告
- 生命科學
- 生物科技 & 生物化學
- 報告資訊
Biotechnology in Italy
出 版 商:MarketLine
出版日期:2019/12/17
頁 數:35頁
文件格式:PDF
Biotechnology in Italy
Summary
Biotechnology in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.
- The Italian biotechnology industry had total revenues of $10.0bn in 2018, representing a compound annual growth rate (CAGR) of 4.8% between 2014 and 2018.
- The medical/healthcare segment was the industry's most lucrative in 2018, with total revenues of $4.2bn, equivalent to 41.7% of the industry's overall value.
- Like other developed European nations, the medical/healthcare segment dominates in Italy, due to an ageing population and an increase in age-associated disease, such as diabetes and cardiovascular diseases.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Italy
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Italy
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Italy biotechnology market with five year forecasts
Reasons to buy
- What was the size of the Italy biotechnology market by value in 2018?
- What will be the size of the Italy biotechnology market in 2023?
- What factors are affecting the strength of competition in the Italy biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Italy's biotechnology market?
Summary
Biotechnology in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.
- The Italian biotechnology industry had total revenues of $10.0bn in 2018, representing a compound annual growth rate (CAGR) of 4.8% between 2014 and 2018.
- The medical/healthcare segment was the industry's most lucrative in 2018, with total revenues of $4.2bn, equivalent to 41.7% of the industry's overall value.
- Like other developed European nations, the medical/healthcare segment dominates in Italy, due to an ageing population and an increase in age-associated disease, such as diabetes and cardiovascular diseases.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Italy
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Italy
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Italy biotechnology market with five year forecasts
Reasons to buy
- What was the size of the Italy biotechnology market by value in 2018?
- What will be the size of the Italy biotechnology market in 2023?
- What factors are affecting the strength of competition in the Italy biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Italy's biotechnology market?
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players in the market?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. What are the weaknesses of leading players?
7.5. Are there any opportunities for leading players?
7.6. Are there any threats to leading players?
8 Company Profiles
8.1. The Menarini Group
8.2. Zambon Co SpA
8.3. Jazz Pharmaceuticals Plc
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players in the market?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. What are the weaknesses of leading players?
7.5. Are there any opportunities for leading players?
7.6. Are there any threats to leading players?
8 Company Profiles
8.1. The Menarini Group
8.2. Zambon Co SpA
8.3. Jazz Pharmaceuticals Plc
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine